Targeting Growth and Development in Medullary Thyroid Cancer Patients
NCT01660984 · RecruitingThis study looks at how medullary thyroid cancer (MTC) affects children and adults over time. MTC is a rare cancer that can be part of a condition called Multiple Endocrine Neoplasia (MEN2). Researchers want to understand MTC's impact on growth and development, especially in people with MEN2. The goal is to learn more about this cancer and improve future treatments.
Locations and contact
This trial is running at 1 location in the United States. It is currently recruiting.
United States1 location · 1 recruiting
- National Institutes of Health Clinical CenterBethesda, MarylandRecruiting
Who can join
This study is open to children and adults, starting from 4 months old, who have medullary thyroid cancer or a diagnosis of MEN2. It is for both men and women, including parents or caregivers of eligible patients. The trial team will confirm who can join.
What happens during the trial
Participants will have a physical exam and medical history taken. They will give blood and tissue samples to check for the MEN2 genetic mutation. While no specific treatment is given in this study, participants will continue their usual care for MTC. They will come in for regular visits every 6 to 12 months for check-ups. Parents or caregivers will also share information about their health and feelings during the study.
The trial team
The National Cancer Institute (NCI) is leading this study. Dr. John W. Glod is the principal investigator overseeing the trial.
Important dates
This trial started on July 30, 2012, and is currently enrolling new participants. It is expected to finish by June 8, 2026.
Additional information
The trial's ID number is NCT01660984. It is an observational study, meaning it aims to watch and learn without giving specific treatments. This study is not focused on an FDA-regulated drug or device. The trial hopes to include around 259 participants.
Other recruiting trials for the same condition, with the eligibility rules written in plain language.
Browse similar trials →Find a top oncologist who can tell you whether a trial is a sensible option for you.
Find a doctor →The cancer centers running studies like this one, and what each is known for.
Browse hospitals →